US Stock MarketDetailed Quotes

STVN Stevanato Group

Watchlist
  • 23.310
  • +0.840+3.74%
Close Dec 13 16:00 ET
  • 23.310
  • 0.0000.00%
Post 20:01 ET
6.36BMarket Cap51.80P/E (TTM)

About Stevanato Group Company

Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.

Company Profile

SymbolSTVN
Company NameStevanato Group
Listing DateJul 16, 2021
Issue Price21.00
Founded1980
CEOMr. Franco Moro
MarketNYSE
Employees5635
Fiscal Year Ends12-31
AddressVia Molinella 17
CityPiombino Dese
ProvincePadova
CountryItaly
Zip Code35017
Phone39-049-9318111

Company Executives

  • Name
  • Position
  • Salary
  • Franco Moro
  • Director and Chief Executive Officer
  • --
  • Marco Dal Lago
  • Chief Financial Officer
  • --
  • Mauro Stocchi
  • Chief Business Officer
  • --
  • Franco Stevanato
  • Executive Chairman of the Board
  • --
  • Riccardo Butta
  • President, Americas
  • --
  • Sergio Stevanato
  • Director and Chairman Emeritus
  • --
  • Marco Stevanato
  • Vice Chairman of the Board
  • --
  • Madhavan Balachandran
  • Director
  • --
  • Dr. Donald Eugene Morel, Jr
  • Director
  • --
  • Paola Vezzaro
  • Director
  • --
  • Fabiano Nicoletti
  • Director
  • --
  • Alvise Spinazzi
  • Director
  • --
  • Fabio Buttignon
  • Independent Director
  • --
  • Dr. Fabrizio Bonanni
  • Independent Director
  • --
  • William J. Federici
  • Independent Director
  • --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.